Long-term patient-reported health-related quality of life in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH Agonist with either bicalutamide or abiraterone acetate plus prednisone and apalutamide after radical prostatectomy Meeting Abstract
| Authors: | Hoffman, K. E.; Nguyen, P. L.; Rathkopf, D.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; Bubley, G.; Yu, J. B.; An, Y.; Wong, A. C.; Feng, F. Y.; McKay, R. R.; Rose, B. S.; Lee, K. Y.; Kibel, A.; Taplin, M. E. A.; Kollmeier, M. A. |
| Abstract Title: | Long-term patient-reported health-related quality of life in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH Agonist with either bicalutamide or abiraterone acetate plus prednisone and apalutamide after radical prostatectomy |
| Meeting Title: | 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2024) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 120 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2024 Sep 29-Oct 2 |
| Meeting Location: | Washington, DC |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S54 |
| Language: | English |
| ACCESSION: | WOS:001325892302550 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2024.07.088 |
| Notes: | Meeting Abstract: 181 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
